December 23, 2020
Reducing the Immunogenicity of Pegloticase in Patients With Refractory Gout
Puja Khanna MD, MPH, discusses a presentation she gave at the American College of Rheumatology Convergence 2020 on reducing the immunogenicity of pegloticase and improving its efficacy.